These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21818622)

  • 21. The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).
    De Schoenmakere G; Lameire N; Dhondt A; Van Loo A; Van der Goten J; Duym P; Vanholder R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1770-5. PubMed ID: 9681726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients.
    Chang CH; Chang CC; Chiang SS
    Clin Nephrol; 2002 Feb; 57(2):136-41. PubMed ID: 11863124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous versus intravenous administration of erythropoietin improves its efficiency for the treatment of anaemia in haemodialysis patients.
    Albitar S; Meulders Q; Hammoud H; Soutif C; Bouvier P; Pollini J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():40-3. PubMed ID: 8524493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcuma decreases serum hepcidin levels in healthy volunteers: a placebo-controlled, randomized, double-blind, cross-over study.
    Lainé F; Laviolle B; Bardou-Jacquet E; Fatih N; Jezequel C; Collet N; Ropert M; Morcet J; Hamon C; Reymann JM; Loréal O
    Fundam Clin Pharmacol; 2017 Oct; 31(5):567-573. PubMed ID: 28370178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of hepcidin expression at high altitude.
    Talbot NP; Lakhal S; Smith TG; Privat C; Nickol AH; Rivera-Ch M; León-Velarde F; Dorrington KL; Mole DR; Robbins PA
    Blood; 2012 Jan; 119(3):857-60. PubMed ID: 22130801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.
    Rhodes CJ; Howard LS; Busbridge M; Ashby D; Kondili E; Gibbs JS; Wharton J; Wilkins MR
    J Am Coll Cardiol; 2011 Jul; 58(3):300-9. PubMed ID: 21737024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study.
    Ogawa C; Tsuchiya K; Tomosugi N; Shimada K; Kanda F; Maeda K
    Hematology; 2020 Dec; 25(1):71-78. PubMed ID: 32009585
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant human erythropoietin-induced erythropoiesis regulates hepcidin expression over iron status in the rat.
    Ribeiro S; Garrido P; Fernandes J; Rocha S; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
    Blood Cells Mol Dis; 2016 Jul; 59():63-70. PubMed ID: 27282570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver iron is a major regulator of hepcidin gene expression via BMP/SMAD pathway in a rat model of chronic renal failure under treatment with high rHuEPO doses.
    Ribeiro S; Garrido P; Fernandes J; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
    Biofactors; 2016 May; 42(3):296-306. PubMed ID: 26990350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.
    Xu Y; Ding XQ; Zou JZ; Liu ZH; Jiang SH; Chen YM
    J Int Med Res; 2011; 39(5):1961-7. PubMed ID: 22118000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperhydration Effect on Pharmacokinetic Parameters and Detection Sensitivity of Recombinant Human Erythropoietin in Urine and Serum Doping Control Analysis of Males.
    Athanasiadou I; Dokoumetzidis A; Voss SC; El Saftawy W; Al-Maadheed M; Valsami G; Georgakopoulos C
    J Pharm Sci; 2019 Jun; 108(6):2162-2172. PubMed ID: 30684541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
    Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients.
    Canavese C; Bergamo D; Ciccone G; Burdese M; Maddalena E; Barbieri S; Thea A; Fop F
    Nephrol Dial Transplant; 2004 Jun; 19(6):1564-70. PubMed ID: 15004263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.
    Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.
    van der Weerd NC; Grooteman MP; Bots ML; van den Dorpel MA; den Hoedt CH; Mazairac AH; Nubé MJ; Penne EL; Gaillard CA; Wetzels JF; Wiegerinck ET; Swinkels DW; Blankestijn PJ; Ter Wee PM;
    PLoS One; 2012; 7(7):e39783. PubMed ID: 22808058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.
    Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Green K; Makdissi A; Chaudhuri A; Dandona P
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):772-780. PubMed ID: 27292585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children.
    Aeberli I; Hurrell RF; Zimmermann MB
    Int J Obes (Lond); 2009 Oct; 33(10):1111-7. PubMed ID: 19636315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
    Malyszko J; Malyszko JS; Mysliwiec M
    Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anemia and carnitine supplementation in hemodialyzed patients.
    Kletzmayr J; Mayer G; Legenstein E; Heinz-Peer G; Leitha T; Hörl WH; Kovarik J
    Kidney Int Suppl; 1999 Mar; 69():S93-106. PubMed ID: 10084293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R; Bloom E; Johnson R
    Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.